Genenta Science S.p.A. (GNTA)

NASDAQ: GNTA · IEX Real-Time Price · USD

3.900

-0.030 (-0.76%)

Apr 19, 2024, 9:32 AM EDT - Market open

Genenta Science Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	5.26	5.71	2.3	0.9	0.92
Research & Development	6.47	5.34	3.39	4.69	3.7
Operating Expenses	11.73	11.04	5.69	5.59	4.62
Operating Income	-11.73	-11.04	-5.69	-5.59	-4.62
Interest Expense / Income	0.31	0.04	-0.01	-0.01	0.01
Other Expense / Income	-0.4	-2.6	-0.15	0.01	-0.04
Pretax Income	-11.65	-8.48	-5.53	-5.59	-4.6
Net Income	-11.65	-8.48	-5.53	-5.59	-4.6
Shares Outstanding (Basic)	18	18	15	18	-
Shares Outstanding (Diluted)	18	18	15	-	-
Shares Change	0.00%	20.77%	-14.34%	-	-
EPS (Basic)	-0.64	-0.47	-0.37	-	-
EPS (Diluted)	-0.64	-0.47	-0.37	-	-
Free Cash Flow	-11.22	-7.45	-6.97	-6.07	-2.49
Free Cash Flow Per Share	-0.62	-0.41	-0.46	-0.34	-
EBITDA	-11.29	-8.43	-5.54	-5.6	-4.59
Depreciation & Amortization	0.04	0.01	0	0	0
EBIT	-11.34	-8.44	-5.54	-5.6	-4.59

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).